Manufacturing Cell and Gene Therapy Products – The Revolution Is Here!
“The Global Cell And Gene Therapy Market Is Estimated To Be Worth Between £9 to £14 Billion Per Year By 2025”
The race towards commercialisation of cell and gene products has already begun. Where technology innovations are pathing the way towards the development of these products, challenges surrounding scale up and closed system processing highlight areas that need our focus so that cell and gene therapy products can be produced on an industrial scale
The Cell and Gene Therapy Manufacturing Forum is the only conference that is 100% dedicated to focusing on development of manufacturing processes for these products. With presentations on improving cost efficiency, innovative strategies for commercialisation as well as closed system processing, optimised manufacturing scheduling and maintaining GMP compliance, this forum is one that is not to be missed!.
2017 Speakers Include:
Executive Vice President Corporate Development
Regulatory Affairs Specialist
Director Global Regulatory Affairs
Technology and Inovation Manager
Process Science Manager – CMC
Chief Regulatory & Compliance Officer
Head of Advanced Therapy Production
Guy's and St Thomas' NHS Foundation Trust and KCL Clinical Research Facility
Production Co ordinator
Head Tyneside Leukaemia Research Laboratories
Newcastle Cellular Therapies Facility
Attend This Forum To:
Determine what needs to be considered when moving from the research stage to commercial production, identifying the opportunities and challenges in ATMP
Look at the different challenges surrounding both open and closed system processing and identify the best approach to enhancing your system
Understand the best method for improving logistics and product stability at the final stages of the bio manufacturing process allowing you to start creating the optimal system
Study what the opportunities and barriers are when looking to scale up production allowing you to plan ahead for your manufacturing process
Scrutinise ways of improving manufacturing flexibility and cost efficiency in your manufacturing process and establish ways of moving towards a continuous bioprocess
What did previous attendees have to say?
“Good mix of speakers”
“Impressed with the standard of presentations and openness of discussion”
So What Makes Our Event Different?
- Our event is case study driven. Only at our event will you hear practical case studies that help you to develop take home strategies to improve you manufacturing processes. Out presenters are sharing strategies that have yielded results for them.
- An entirely unique speaker panel! No matter which events you have attended in the past, Cell and Gene Therapy Manufacturing will offer you insight from brand new speakers, and companies that will be presenting case studies for the first time ever!
- A targeted focus on manufacturing. Our event focuses on the key challenges of manufacturing cell and gene therapies including scale up and scale out, automation, closed system processing and multiple product manufacturing
- Regulation and Logistics workshops - that will help you drill down to you main pain points and knowledge share with peers